Bioventus Inc.

BVS Nasdaq CIK: 0001665988

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
Phone (919) 474-6700
Fiscal Year End 1231
EIN 810980861

Financial Overview

FY2024

-$33.54M
Net Income
$173.59M
Stockholders' Equity
$41.58M
Cash & Equivalents
$-0.52
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
4 Insider stock transaction report January 13, 2026 View on SEC
4 Insider stock transaction report December 8, 2025 View on SEC
3 Initial insider ownership report November 25, 2025 View on SEC
8-K Current report of material events November 17, 2025 View on SEC
4 Insider stock transaction report November 10, 2025 View on SEC
10-Q Quarterly financial report November 4, 2025 View on SEC
8-K Current report of material events November 4, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment August 14, 2025 View on SEC
8-K Current report of material events August 6, 2025 View on SEC

Insider Trading

SELL 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.